Latest News on GRAL

Financial News Based On Company


Advertisement
Advertisement

Stock Market News for May 23, 2025

https://www.zacks.com/stock/news/2476648/stock-market-news-for-may-23-2025
U.S. stocks markets closed mixed after a choppy session.

Shake Shack, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - GRAIL ( NASDAQ:GRAL ) , Oklo ( NYSE:OKLO )

https://www.benzinga.com/trading-ideas/movers/25/05/45493256/shake-shack-tesla-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
U.S. stock futures were lower this morning, with the Dow futures falling around 300 points on Monday. Shares of Shake Shack Inc. SHAK fell sharply in today's pre-market trading. TD Securities analyst Andrew Charles downgraded the rating for Shake Shack from Buy to Hold and maintained the price ...

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Alcon ( NYSE:ALC ) , American Eagle Outfitters ( NYSE:AEO )

https://www.benzinga.com/trading-ideas/movers/25/05/45404297/alcon-american-eagle-grail-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-sessio
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Wednesday. Shares of Alcon Inc ALC fell sharply in today's pre-market trading as the company posted downbeat results for the first quarter on Tuesday.

Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Absci ( NASDAQ:ABSI ) , Abpro Hldgs ( NASDAQ:ABP )

https://www.benzinga.com/trading-ideas/movers/25/05/45400617/why-everus-construction-group-shares-are-trading-higher-by-around-15-here-are-20-stocks-movi
Shares of Everus Construction Group, Inc. ECG rose sharply in today's pre-market trading after the company posted better-than-expected first-quarter results. Everus Construction Group reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 43 cents per share.

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Quest Diagnostics ( NYSE:DGX )

https://www.benzinga.com/general/biotech/25/04/44929366/quest-diagnostics-revenue-rebound-strategic-moves-fuel-outlook-confidence
Q1 revenue rose 12.1% to $2.65 billion, beating estimates; adjusted EPS climbed 8.3% to $2.21. Adjusted operating income grew 16.3% to $406 million; margin expanded to 15.3% from 14.8%. China's new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for ...
Advertisement

Jim Cramer Asks Trump To Take Stock As Markets Swing Again Ahead Of 'Liberation Day' - Discover Financial servs ( NYSE:DFS ) , GRAIL ( NASDAQ:GRAL )

https://www.benzinga.com/markets/25/03/44577159/jim-cramer-asks-trump-to-take-stock-as-markets-swing-again-ahead-of-liberation-day
U.S. markets continued to witness volatility on Monday as President Donald Trump's 'Liberation Day' fast approaches, bringing a volley of tariffs across products, industries, allies, and adversaries. Leading analysts and experts have since urged the President to reconsider his trade policy stance.

QuidelOrtho Unveils Results Manager System to Streamline Testing

https://www.zacks.com/stock/news/2430247/quidelortho-unveils-results-manager-system-to-streamline-testing
QDEL introduces the Results Manager System, a powerful tool designed to streamline diagnostic data management, enhance efficiency, and improve patient care.

Grail Shares Spiked Wednesday: What's Going On? - GRAIL ( NASDAQ:GRAL )

https://www.benzinga.com/trading-ideas/movers/25/02/43674133/grail-shares-were-up-today-whats-going-on
GRAIL partners with Quest Diagnostics to integrate its Galleri multi-cancer early detection test into Quest's system. Stock surges despite the announcement, indicating investor concerns about the immediate impact and costs of the initiative.

Stock Market News for Feb 6, 2025

https://www.zacks.com/stock/news/2410667/stock-market-news-for-feb-6-2025
U.S. stock markets closed higher on Wednesday posting back-to-back closing in green.

Jim Cramer Recommends Buying 'Fabulous' BlackRock, Calls Coterra Energy The 'Cheapest' Natural Gas Company - BlackRock ( NYSE:BLK ) , Coterra Energy ( NYSE:CTRA )

https://www.benzinga.com/25/01/43266082/jim-cramer-coterra-energy-is-the-cheapest-natural-gas-company-recommends-buying-this-financial-stock
"The long-term growth rate of this thing is fabulous, and I think it's going to stay that way," Cramer on BlackRock. Raymond James analyst John Freeman, on Jan. 23, maintained Coterra Energy with an Outperform rating and raised the price target to $41. Get Wall Street's Hottest Chart Every Morning
Advertisement

Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday - Absci ( NASDAQ:ABSI ) , ARM Holdings ( NASDAQ:ARM )

https://www.benzinga.com/25/01/43130999/seagate-posts-upbeat-earnings-joins-netflix-travelers-teledyne-technologies-and-other-big-stocks-moving-higher-on
U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Wednesday. Shares of Seagate Technology Holdings plc STX rose sharply during Wednesday's session after the company reported second-quarter EPS and revenues above analyst estimates.

What's Going On With Illumina Stock On Monday? - Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/24/12/42514960/whats-going-on-illumina-stock-on-monday
On Friday, Nasdaq Inc's NDAQ annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. Illumina, Inc. ILMN was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF IJH.

Cell-Free DNA Mutation Diagnostics Market to Surge to US$ 81,584.2 Million by 2034, Growing at a CAGR of 24.9% | Fact.MR Report

https://www.benzinga.com/pressreleases/24/12/g42334329/cell-free-dna-mutation-diagnostics-market-to-surge-to-us-81-584-2-million-by-2034-growing-at-a-cag
Rockville, MD , Dec. 05, 2024 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global Cell-free DNA Mutation Diagnostics Market is estimated to reach a valuation of US$ 8,830.4 million in 2024 and is expected to grow at a CAGR of 24.9% ...

European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine - Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/m-a/24/09/40688420/european-court-rules-in-favor-of-illumina-in-fight-against-probe-into-grail-deal-asks-not-to-pay-478
Provider of DNA sequencing and array-based technologies, Illumina, Inc. ILMN said it welcomes the European Court of Justice's ( ECJ's ) judgment ruling that the European Commission did not have jurisdiction over Illumina's acquisition of GRAIL.

Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?

https://markets.businessinsider.com/news/stocks/dow-rallies-to-all-time-highs-small-caps-outperform-tech-gold-hits-records-on-heightened-september-rate-cut-bets-what-s-driving-markets-tuesday-1033560528
Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in September.
Advertisement

news

https://www.prnewswire.com/news/grail%2C-inc./
GRAIL, Inc. ( NASDAQ: GRAL ) , a healthcare company whose mission is to detect cancer early when it can be cured, today provided an update on the... Join PR Newswire for Journalists to access all of the free services designated to make your job easier. In need of subject matter experts for ...

Why Is Illumina Stock trading Higher On Wednesday? - Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39714633/illumina-buys-fluent-biosciences-to-gain-stronger-foothold-in-single-cell-analysis
Last month, Illumina Inc ILMN had to let go of Grail Inc. GRAL. Still, the DNA sequencing company has acquired Fluent BioSciences to expand its reach in single-cell analysis and multiomics research. Launched in 2018, Fluent was backed by Illumina's venture capital arm.
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion